Advertisement

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah A. Meadows, Sarah E. M. Herman, Adam Kashishian, Bart Steiner, Amy J. Johnson, John C. Byrd, Jeffrey W. Tyner, Marc M. Loriaux, Mike Deininger, Brian J. Druker, Kamal D. Puri, Roger G. Ulrich and Neill A. Giese

Article Information

Citation 
vol. 117 no. 2 591-594
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted March 30, 2010
  • Accepted October 3, 2010
  • Published online January 13, 2011.

Article Versions


Contributors 
  • Brian J. Lannutti, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Sarah A. Meadows, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Sarah E. M. Herman, 2Comprehensive Cancer Center, The Ohio State University, Columbus, OH; and
  • Adam Kashishian, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Bart Steiner, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Amy J. Johnson, 2Comprehensive Cancer Center, The Ohio State University, Columbus, OH; and
  • John C. Byrd, 2Comprehensive Cancer Center, The Ohio State University, Columbus, OH; and
  • Jeffrey W. Tyner, 3Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR
  • Marc M. Loriaux, 3Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR
  • Mike Deininger, 3Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR
  • Brian J. Druker, 3Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR
  • Kamal D. Puri, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Roger G. Ulrich, 1Calistoga Pharmaceuticals Inc, Seattle, WA;
  • Neill A. Giese, 1Calistoga Pharmaceuticals Inc, Seattle, WA;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output